PubMed Systematic reviewPCOS and GLP-1 evidence2019 GLP-1 receptor agonists versus metformin in PCOS: a systematic review and meta-analysis Used for PCOS pages comparing metabolic and weight-management approaches
Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
Nor is he completely convinced of danugliprons safety: Are we sure danuglipron wont suffer lotigliprons fate? Danuglipron is much further along so its definitely passed the safety hurdle lotiglipron didnt, Raffat continued
If the medication has been exposed to direct sunlight for more than a few hours, treat it as compromised
He speculates that GLP-1 receptors in some people may have genetic differences that might influence how well the hormone binds to the receptor and activates subsequent insulin and satiety pathways
Moreover, mitochondria from substantia nigra neurons, skeletal myocytes, and platelets show inhibited enzyme activities in the ETC (particularly complex I) [104,105,106]
